Contineum Therapeutics Q3 EPS $(0.49) Misses $(0.45) Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings Misses
Contineum Therapeutics (NASDAQ:CTNM) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.45) by 8.89 percent. This is a 8.89 percent decrease over losses of $(0.45) per
Contineum Therapeutics (NASDAQ:CTNM) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.45) by 8.89 percent. This is a 8.89 percent decrease over losses of $(0.45) per share from the same period last year.